NeoGenomics, Inc. (NEO)
7.995
+0.24
(+3.16%)
USD |
NASDAQ |
Apr 02, 16:00
8.00
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Shareholders Equity (Quarterly) : 836.56M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 477.32M |
| Amphastar Pharmaceuticals, Inc. | 788.80M |
| Krystal Biotech, Inc. | 1.220B |
| Alignment Healthcare, Inc. | 179.28M |
| Monte Rosa Therapeutics, Inc. | 233.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.360B |
| Total Liabilities (Quarterly) | 523.27M |
| Debt to Equity Ratio | 0.4895 |
| Current Ratio | 4.260 |
| Net Debt Paydown Yield | 2.59% |